mRNAs. 4, 5 Because miRNAs imperfectly complement their targets, they are able to interact with tens to hundreds of gene products in various signaling pathways to ultimately regulate cell functions. This also indicates the diversity of miRNAs functions.
MiR-374 family members (including A (a), B (b) and C (c)), as splic-
ing segments of the lncRNA FTX, are located at the X-inactivation center (Xic) of chromosomes Xq13.2 in humans. 8 An increasing number of studies have shown that these members participate in a great diversity of physiological and pathological processes. In this review, we mainly summarize the role of miR-374 family members, a highly conserved miRNA cluster in evolution, in different physiological and pathological processes. More importantly, we also discuss their potential function in the diagnosis and treatment of miR-374 related diseases, especially cancer.
| THE DELIVERY OF MIR-374 AND ITS ROLE IN DE VELOPMENT
In mammalian development, X-chromosome inactivation (XCI) is well-known for epigenetic regulation. 9, 10 Mounting studies have
shown that female embryos will die without XCI, which corroborates the significance of this epigenetic regulatory mechanism in the development of female embryos. 10, 11 The transcriptional silencing of an X chromosome often corrects an imbalance of Xlinked gene dosage. One cis-acting element, named Xic, controls and regulates XCI. There are several transcripts that are located in Xic and can escape XCI, including X-inactive-specific transcript (XIST), TSIX (TSIX transcript, XIST antisense RNA), JPX (JPX transcript, XIST activator), FTX (FTX transcript, XIST regulator) and miRNAs generated from the FTX sequence by cleavage, 12, 13 which may lead to gender disparity ( Figure 1 ). Overwhelming data have implicated that XIST, the master regulator of X-inactivation initiation, is a single and central cis-acting regulator that coordinates imprinted XCI.
11,14
In addition to XIST, FTX is also one of the most abundant transcripts at the stage of preimplantation embryo and is thought to be a positive regulator of XIST. 13, 15 It is a well-conserved lncRNA in evolution and includes several conserved miRNAs, such as miR-374, -545 and -421, in its introns. 16 In humans, intron 1 encodes a cluster of 2 miRNAs (MIR-374A and MIR-545), which is absent in rats and mice; intron 5 encodes a cluster of 3 miRNAs (MIR-374B, C and MIR-421) ( Figure 1B ). In addition, the sequences of miR-374 family members are highly conserved in different mammalian species, especially in miR-374-5p ( Figure 2 ).
In recent years, studies have shown that these miRNAs, which are located at Xic, are also imprinted and involved in mammalian development and the generation of paternal sperm. For example, Kobayashi et al 10 reported that miR-374-5p and miR-421-3p mapped adjacent to Xist, were both predominantly expressed in female blastocysts from the Xp chromosome in F1 blastocysts and were indeed imprinted, as determined by allelic expression analysis. In addition,
there is another report 17 that miR-374b is markedly decreased in the seminal plasma of azoospermia but is increased in the seminal plasma of asthenozoospermia, as shown by Solexa sequencing and RT-qPCR analysis. The area under the receiver operating characteristic (ROC)
curve of miR-374b is 0.839 in the 73 azoospermia cases and 0.813 in the 79 asthenozoospermia cases. The authors point out this is markedly higher than for routine biochemical parameters (0.510-0.622).
Their results revealed that miR-374b level in seminal plasma is a novel, non-invasive approach for diagnosing male infertility.
| THE ROLE OF MIR-374 IN TUMORIG ENE S IS
Most likely because of the advancement of preventive examinations and therapeutic interventions, epidemiological studies have provided strong support for the decrease of the mortality rate due to cancer. Nevertheless, the heterogeneous complex of cancers still remains one of the leading causes of premature death worldwide. 18 Recent reports have verified the presence of ncRNAs, including lncRNA, miRNAs, circular RNAs and so on, in the human cancer.
19,20
We will summarize the role of miR-374 family members in the development and progression of different systematic cancers in this section.
| miR-374 and digestive system carcinoma
The digestive system, as one of the eight systems of the human body, is composed of two parts: the digestive tract and digestive glands. The liver, as one of the important digestive glands, plays an indispensable role in body metabolism, including the storage of glycogen, the synthesis of plasma protein, the decomposition of red blood cells, and the detoxification of toxic substances. Meanwhile, because the liver is a fragile organ, poor protection will lead to the decline of normal function and the development of disease (such as hepatitis and hepatocellular carcinoma). In 2017, Bao et al 21 reported
that miR-374 levels were significantly decreased as HBV-related liver fibrosis progressed from S0-S2 to S3-S4. In addition, they identified that miR-374 had a highly diagnostic accuracy in discriminating S0-S2 from S3-S4 using multivariate logistic regression analysis. In recent years, our research group has been unanimously committed to the study of liver disease. comprehensively analysed the function of miR-374b from colon cancer tissues to cell lines. First, they showed that the expression of miR-374b was significantly reduced in colon cancer tissues and cell lines. Second, they investigated the effect and mechanism of miR-374b and found that its overexpression inhibited cell proliferation and invasion, while the role of its knockdown was exactly opposite. Ultimately, they verified that LRH-1 is a direct target of miR-374b via a dual-luciferase reporter assay, and then they showed that miR-374b can suppresses the Wnt signaling pathway through LRH-1 in colon cancer cells.
In recent years, there have also been some reports about the relationship between miR-374 and gastric cancer. Xie J showed that the expression of miR-374b-5p was up-regulated and conducive to gastric cancer cell invasion and metastasis via inhibiting the expression of RECK. 24 Ji et al 25 30 The latest report 31 confirmed that miR-374 may also participate in the pathogenesis of pituitary gonadotroph adenomas by bioinformatics analysis. However, the author did not discuss the specific mechanism of miR-374 in this disease. 
| miR-374 and chemoradiotherapy of tumor
Presently, cancer treatment mainly includes three types: surgi- Therefore, miR-374 may be a novel chemosensitizer and/or radiosensitizer and will be a new potential biomarker for deciding the optimal treatment for cancer. Accumulated data have shown that miR-374 regulates cell growth and differentiation not only in rodents but also in poultry.
| THE ROLE OF MIR-37IN CELL G ROW TH AND D IFFERENTIATI ON UNDER PHYS IOLOG IC AL CONDITIONS
In 2013, Pan et al 43 showed that dexamethasone-induced miR-374a
and miR-374b promoted the differentiation of primary porcine adipocytes by targeting 3′-UTR of C/EBP-β. In the same year, Su et al 44 found that miR-374 contributed to goat hair production both in entering growth and cessation stages by the analysis of comparative genomics combined with an expression profile assay. induced a rat TLE model with pentylenetetrazol. They also analysed the dysregulated miRNAs in the hippocampus by microRNA expression profiles and found that there were four up-regulated miRNAs, including miR-374.
| THE ROLE OF MIR-374 IN K IDNE Y DISE A SE

| miR-374 and neurodegeneration
Degenerative changes (including drug-induced and physiological) in the nervous system seriously threaten people's health. In recent years, research on the degenerative changes of the nervous system by miRNAs has grown. Wang et al 61 found that PQ-and MPTP-treatment inhibited the expression of miR-374-5p (P < 0.01) in Neuro-2a
cells. Yet, miR-374-5p was not associated with several biological processes including regulation of DNA dependent transcription and RNA metabolic processes in the pathogenesis of Parkinson's disease.
Moreover, Manzine 62 reported that miR-374 levels were significantly diminished in AD compared with the control group. Furthermore, miR-374 may directly target relevant AD genes such as BACE1 to regulate the progress of AD.
Amyotrophic lateral sclerosis (ALS) is one of the most common
adult onset neurodegenerative diseases with a prevalence of 6-8 per 100 000. 63 It is a complex disease with multiple pathogenic mechanisms (including excitotoxicity, oxidative stress, protein aggregation, mitochondrial dysfunction, dysregulated endosomal trafficking, defective axonal transport, dysregulation of RNA processing, and neuroinflammation). 64 In 2017, Waller et al 65 reported
that miR-374b-5p was significantly decreased in patient serum over time compared with 23 sALS and 22 control subjects. And it may be a compensatory role in the degeneration of muscle in ALS and be an attempt to support muscle regeneration and restore a balance by enhancing myoblast differentiation, and thus it could be used as a biomarker to assess treatment efficacy and potentially disease prognosis.
| miR-374 and other diseases in the nervous system
Hypoxic-ischemic encephalopathy (HIE) is a disease defined as ischemic injury caused by hypoxic asphyxia during the perinatal period. Late diagnosis partially leads to high mortality (approximately 15%-20%) of this diease. Therefore, finding new biomarkers to improve the diagnostic value of neuron-specific enolase (NSE) and S100B protein is especially important. In 2017, Wang et al 66 reported
that the expressions of miR-210 and miR-374a, considered to be two important hypoxia-associated miRNAs, were down-regulated in blood samples of HIE newborns compared with those of healthy newborns. Joint analysis of miR-210, miR-374a, S100B protein and NSE help to elevate the diagnostic value and prognostic prediction for HIE by the ROC curves assay.
| THE ROLE OF MIR-374 IN C ARDIOVA SCUL AR DIS E A S E
Studies showed that miR-374 family members can also regulate the pathophysiological process of cardiovascular disease. Early 
| THE ROLE OF MIR-374 IN IMMUNE-REL ATED D IS E A S E
CD56 is invariably expressed in normal natural killer cell, They showed that miR-374b was markedly down-regulated in the T-ALL tissues by microRNA microarray analysis, and the down-regulated miR-374b was greatly associated with worse survival and higher relapse rates in patients with T-ALL. miR-374b overexpression restrained tumorigenicity and cell proliferation, and it accelerated cell apoptosis though targeting Wnt-16 and AKT1, which led to inhibition of AKT signal pathway.
Acute graft-versus-host disease (aGvHD) has a higher mortality rate, the most frequent and serious complication. Expression analysis 77 identified miR-374-5p as significantly down-regulated and with diagnostic value by ROC analysis in aGvHD.
Moreover, Delić et al 78 verified that, after female C57BL/6 mice were infected with self-healing Plasmodium chabaudi malaria, hepatic miR-374* expression was down-regulated. In addition, Uribe et al 79 found that miR-374a-5p expression was up-regulated in porcine intestinal mucosa infected with Salmonella Typhimurium by
Microarray hybridization and analysis and RT-qPCR assay.
| THE ROLE OF MIR-374 IN OTHER DISE A SE S
Bhargava et al 80 found that miR-374 affected the function of rat AT2 epithelial cells during hyperoxic stress and recovery through three possible targets, including actinin alpha 4, actinin alpha 1, and Na,
In addition, some have directly observed the relationship be- 
| CON CLUS I ON S AND PER S PEC TIVE S
In conclusion, as shown in Table 1 TA B L E 1 (Continued) (Continues) different pathological and physiological conditions. This will also be a deficiency in this area.
Therefore, there is still a long way to go until they are used in disease prediction and targeted therapy. So we should accelerate the process of translation of preclinical results into clinic and make them into phase I and II trials to guide clinical diagnosis and treatment. But, this will be a large challenge and hard to pursue in the future. Indeed, the safety (activation of viral delivery systems to immune response, off-target effect of ncRNAs, competition with endogenous miRNAs and multi-targeting of miRNAs) of ncRNAs, as clinical therapeutic targets, needs to be established with certainty. 
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